History & Expertise

10 years of proteomic platform development - 30 Years of translational research

10 years of proteomic platform development - 30 Years of translational research

Aeirtec’s longstanding cellular and clinical pharmacology expertise also assists in multivariate data interpretation in our partnerships on development of disease detection, stratification and monitoring biomarker panels.

In parallel to development of the novel proteomics platform for use in patient screening, monitoring and life science research, Aeirtec has consolidated their expertise in neuro and immune biomarker monitoring through direct engagement in design and conduct of clinical research and clinical trials.

  • Altana

    AstraZeneca

    Boehringer Ingelheim

    UCB

    GSK

    Novartis

    Pfizer

Platform Patent Progress

Immobilized Bead Multiplex Assay Patent

-awarded

High Assay Sensitivity Analysis Equations Patent

-awarded

Proteomic Bead Imaging Patent

-pending

Our Collaborative Expertise

  • Patented Technology

    High sensitivity high dynamic range multiplexing platform from Aeirtec

    Learn More >

  • Our Experience

    Examples of our work and expertise

    Learn More >

  • Customization of Markers

    Clinical condition specific marker panel customization

    Learn More >

  • Multivariate Biostatistics

    Better data interpretation with multivariate biostatistics

    Learn More >